Geron Corporation (GERN): Price and Financial Metrics
Geron Corporation (GERN)
Today's Latest Price: $1.78 USD
0.01 (-0.56%)
Updated Dec 3 11:25am
Add GERN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GERN Stock Summary
- With a price/sales ratio of 1,485.95, Geron Corp has a higher such ratio than 99.48% of stocks in our set.
- With a year-over-year growth in debt of 8,404.01%, Geron Corp's debt growth rate surpasses 99.49% of about US stocks.
- As for revenue growth, note that GERN's revenue has grown -43.67% over the past 12 months; that beats the revenue growth of just 6.87% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Geron Corp, a group of peers worth examining would be SPCE, CBMG, ARNA, MRSN, and CRNX.
- Visit GERN's SEC page to see the company's official filings. To visit the company's web site, go to www.geron.com.
GERN Stock Price Chart Interactive Chart >
GERN Price/Volume Stats
| Current price | $1.78 | 52-week high | $2.40 |
| Prev. close | $1.79 | 52-week low | $0.75 |
| Day low | $1.78 | Volume | 549,491 |
| Day high | $1.82 | Avg. volume | 2,587,548 |
| 50-day MA | $1.86 | Dividend yield | N/A |
| 200-day MA | $1.64 | Market Cap | 552.64M |
Geron Corporation (GERN) Company Bio
Geron Corporation focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Loading social stream, please wait...